CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- 4 Shares withheld for taxes CVP,Strategy/Corp Development gave up 988 shares (to pay taxes)
- 4 Shares withheld for taxes CVP, Chief Financial Officer gave up 1,283 shares (to pay taxes)
- 4 Planned sale CVP,Strategy/Corp Development sold 9,500 shares at $69.81 ($663,196)
- 4 Planned sale CVP, JAPAC sold 300 shares at $70.61 ($21,183)
- 4 Planned sale CVP, Chief Financial Officer sold 11,250 shares at $70.87 ($797,267)
- 4 Planned sale CVP,Strategy/Corp Development sold 9,500 shares at $67.96 ($645,624)
- 4 Planned sale CEO sold 6,164 shares at $69.51 ($428,448)
- 4 Planned sale CVP, JAPAC sold 400 shares at $69.48 ($27,792)
- 4 Planned sale CVP, Chief Financial Officer sold 11,250 shares at an average $70.78 ($796,327)
- 4 Shares withheld for taxes SVP, Corporate Controller gave up 176 shares (to pay taxes)
- 4 Shares withheld for taxes CVP, JAPAC gave up 601 shares (to pay taxes)
- 4 Shares withheld for taxes CVP, Chief Financial Officer gave up 174 shares (to pay taxes)
- 4 Shares withheld for taxes Global President TAVR & Surg gave up 333 shares (to pay taxes)
- 4 Open-market sale Director sold 5,739 shares at $76.42 ($438,576)
- 4 Planned sale CVP, Chief Financial Officer sold 11,250 shares at $75.76 ($852,272)
- 4 Planned sale CVP,Strategy/Corp Development sold 6,500 shares at an average $75.75 ($492,363)
- 4 Planned sale CVP, JAPAC sold 500 shares at $76.34 ($38,170)
- 4 Open-market sale Director sold 5,739 shares at $75.86 ($435,371)
- 3/A Insider 3/A
- 4 Planned sale CVP, JAPAC sold 500 shares at $68.76 ($34,382)
Page 7 of 94 · 1,865 filings